AutoDELFIA® immunoassay system for prenatal screening is supported by the widest available range of prenatal analytes available on any platform. Reliable and easy to use AutoDELFIA instrument offers high quality results both for aneuploidy and pre-eclampsia risk assessment during pregnancy.
This version of the 1420 VICTOR™ EnLite™ fluorometer is supplied with a stacker to allow semi-automatic operation. The instrument may also be used without the stacker, and plates may then be loaded manually.
The VICTOR2™ D fluorometer is designed for all PerkinElmer diagnostic and screening assays based on either time-resolved fluorescence or prompt fluorescence. VICTOR2 D includes MultiCalc software for assay evaluation and quality control.
DELFIA® Xpress random access platform for prenatal screening. Confidence in your results, total flexibility of a random access system, full range of 1st and 2nd trimester kits for prenatal and pre-eclampsia screening
TriNEST incubator shaker is a high-quality solution for all well plate applications, where accurate and fast temperature and/or shaking control are needed. TriNEST is a first-class choice for e.g. primer extension and DNA hybridization. For rapid cooling, a cooling block is now also available.
TQD (Tandem Quadrupole Detector) represents the latest MSMS instrumentation for newborn screening applications. TQD combines the known robust features from the Quattro micro MSMS instrument with further improved scan speed and sensitivity.
Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in adequate amounts. The condition can easily be treated with daily doses of thyroid hormones but clinical diagnosis is difficult to establish and the disease may continue unrecognized for a long time causing irreversible brain damage.
Galactosemia is an inherited disorder caused by a deficiency of one of three enzymes responsible for the metabolism of α-D-galactose. The most common form of the disease, classic galactosemia is caused by deficiency of galactose-1-phosphate uridyltransferase (GALT).
The DELFIA® Xpress PAPP-A kit is intended for the quantitative determination of PAPP-A (Pregnancy Associated Plasma Protein A) in maternal serum. The kit is used for screening for the risk of Down’s syndrome and as an aid in screening pregnant women for pre-eclampsia in the first trimester of pregnancy.
This kit is intended for the quantitative determination of human immunoreactive trypsin(ogen) (IRT) in blood specimens dried on filter paper as an aid in screening newborns for cystic fibrosis using the 1235 AutoDELFIA® automatic immunoassay system.
The DELFIA®/AutoDELFIA® PlGF 1-2-3 kit quickly and accurately detects levels of Placental Growth Factor (PlGF) in maternal serum. The kit may be used with either the AutoDELFIA automated immunoassay system or the manual DELFIA system.
DELFIA Neonatal hTSH kits are intended for the quantitative determination of human thyroid stimulating hormone (hTSH) in blood specimens dried on filter paper as an aid in screening newborns for congenital hypothyroidism.
The NeoBase Succinylacetone Solution is intended for use with the NeoBase Non-derivatized MSMS Kit for the measurement and evaluation of succinylacetone from newborn heel prick blood samples dried on filter paper.
The Haemoglobin FASC control is intended to be used as a position marker monitor for haemoglobin variant analysis methods and to assess assay reproducibility in the following assay types: ion exchange HPLC, capillary electrophoresis, cellulose acetate and agar/agarose gel electrophoresis and iso-electric focusing.
The DELFIA®/AutoDELFIA® PlGF kit quickly and accurately detects levels of Placental Growth Factor (PlGF) in maternal serum (free PlGF, isoform 1). The kit may be used with either the AutoDELFIA automated immunoassay system or the manual DELFIA system.
The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome.
The NeoBase™ 2 Succinylacetone Assay Solution is intended for in vitro diagnostic use with the NeoBase 2 Non-derivatized MSMS kit (3044-0010) and the NeoBase 2 Non-derivatized Assay Solutions (3045-0010) to extract succinylacetone from blood samples dried on filter paper. Measurement of argininosuccinic acid requires use of NeoBase 2 Succinylacetone Assay Solution.
Neonatal Biotinidase kit is intended for the semi-quantitative determination of biotinidase activity in blood specimens dried on filter paper as an aid in screening newborns for biotinidase deficiency.
This kit is intended for the quantitative determination of human 17-OH-progesterone in blood specimens dried on filter paper as an aid in screening newborns for congenital adrenal hyperplasia (CAH) using the 1235 AutoDELFIA® automatic immunoassay system.
This kit is intended for the quantitative determination of human thyroxine (T4) in bloodspecimens dried on filter paper as an aid in screening newborns for congenital (neonatal) hypothyroidism using the 1235 AutoDELFIA® automatic immunoassay system.
DELFIA® Xpress PAPP-A kit quickly and accurately detects levels of Pregnancy Associated Plasma Protein A (PAPP-A) in maternal serum. Typically in a normal pregnancy, the maternal serum level of PAPP-A increases throughout the pregnancy until term.
Wallac DELFIA® and AutoDELFIA™ uE3 Kits are for the quantitative determination of human unconjugated Estriol (uE3) in serum. Maternal Estriol levels have been used to monitor fetal status during pregnancy. Decreased levels of uE3 can be seen in pregnancies affected with Down´s syndrome in the second trimester of the pregnancy.
Congenital adrenal hyperplasia (CAH) is a genetic disorder and the most severe form of the disease can lead to a life threatening condition during the first weeks of life. The disease is caused by enzyme defects in steroid biosynthesis, the most frequent types being 21- and 11α-hydroxylase deficiency.
Neonatal Total Galactose kit is intended for the quantitative determination of total galactose (galactose and galactose-1-phosphate) concentrations in blood specimens dried on filter paper as an aid in screening newborns for galactosemia.
The NeoGram Derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoGram Amino Acids and Acylcarnitines (AAAC) Tandem Mass Spectrometry Kit. The product includes NeoGram AAAC Flow Solvent, NeoGram AAAC Extraction Solution, NeoGram AAAC Reconstitution Solution and 3.0 N HCL in n-butanol.
The GSP® is a high throughput batch analyzer intended for quantitative or qualitative measurement of neonatal screening samples on 96-well microplates. The instrument is fully automated, performing every stage of an assay from retrieval of the sample plate from the stacker to measurement and reporting of results.
The PerkinElmer EnLite Neonatal TREC kit, 1 x 384 reactions is a CE-marked product used with the VICTOR™ EnLite™ instrument for the quantitative determination of TREC (T-cell receptor excision circle) DNA in blood specimens dried on a filter paper.
The MSMS Vitamin D Kit is an in vitro diagnostic high performance liquid chromatography tandem mass spectrometry (HPLC-MSMS) reagent kit, intended for the quantitative determination of 25-hydroxy-vitamin D2 and 25-hydroxy-vitamin D3 in human serum samples.